Role of Resultant Dipole Moment in Mechanical Dissociation of Biological Complexes. 2018

Maksim Kouza, and Anirban Banerji, and Andrzej Kolinski, and Irina Buhimschi, and Andrzej Kloczkowski
Faculty of Chemistry, University of Warsaw, Pasteura 1, 02-093 Warsaw, Poland. mkouza@chem.uw.edu.pl.

Protein-peptide interactions play essential roles in many cellular processes and their structural characterization is the major focus of current experimental and theoretical research. Two decades ago, it was proposed to employ the steered molecular dynamics (SMD) to assess the strength of protein-peptide interactions. The idea behind using SMD simulations is that the mechanical stability can be used as a promising and an efficient alternative to computationally highly demanding estimation of binding affinity. However, mechanical stability defined as a peak in force-extension profile depends on the choice of the pulling direction. Here we propose an uncommon choice of the pulling direction along resultant dipole moment (RDM) vector, which has not been explored in SMD simulations so far. Using explicit solvent all-atom MD simulations, we apply SMD technique to probe mechanical resistance of ligand-receptor system pulled along two different vectors. A novel pulling direction-when ligand unbinds along the RDM vector-results in stronger forces compared to commonly used ligand unbinding along center of masses vector. Our observation that RDM is one of the factors influencing the mechanical stability of protein-peptide complex can be used to improve the ranking of binding affinities by using mechanical stability as an effective scoring function.

UI MeSH Term Description Entries
D008024 Ligands A molecule that binds to another molecule, used especially to refer to a small molecule that binds specifically to a larger molecule, e.g., an antigen binding to an antibody, a hormone or neurotransmitter binding to a receptor, or a substrate or allosteric effector binding to an enzyme. Ligands are also molecules that donate or accept a pair of electrons to form a coordinate covalent bond with the central metal atom of a coordination complex. (From Dorland, 27th ed) Ligand
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations
D011506 Proteins Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein. Gene Products, Protein,Gene Proteins,Protein,Protein Gene Products,Proteins, Gene
D046911 Macromolecular Substances Compounds and molecular complexes that consist of very large numbers of atoms and are generally over 500 kDa in size. In biological systems macromolecular substances usually can be visualized using ELECTRON MICROSCOPY and are distinguished from ORGANELLES by the lack of a membrane structure. Macromolecular Complexes,Macromolecular Compounds,Macromolecular Compounds and Complexes,Complexes, Macromolecular,Compounds, Macromolecular,Substances, Macromolecular
D054730 Protein Interaction Domains and Motifs Protein modules with conserved ligand-binding surfaces which mediate specific interaction functions in SIGNAL TRANSDUCTION PATHWAYS and the specific BINDING SITES of their cognate protein LIGANDS. Protein Interaction Domains,Protein Interaction Motifs,Binding Motifs, Protein Interaction,Protein Interaction Binding Motifs,Protein-Protein Interaction Domains,Domain, Protein Interaction,Domain, Protein-Protein Interaction,Domains, Protein Interaction,Domains, Protein-Protein Interaction,Motif, Protein Interaction,Motifs, Protein Interaction,Protein Interaction Domain,Protein Interaction Motif,Protein Protein Interaction Domains,Protein-Protein Interaction Domain
D055550 Protein Stability The ability of a protein to retain its structural conformation or its activity when subjected to physical or chemical manipulations. Protein Stabilities,Stabilities, Protein,Stability, Protein
D055595 Mechanical Phenomena The properties and processes of materials that affect their behavior under force. Mechanical Concepts,Mechanical Processes,Mechanical Phenomenon,Mechanical Process,Concept, Mechanical,Concepts, Mechanical,Mechanical Concept,Phenomena, Mechanical,Phenomenon, Mechanical,Process, Mechanical,Processes, Mechanical

Related Publications

Maksim Kouza, and Anirban Banerji, and Andrzej Kolinski, and Irina Buhimschi, and Andrzej Kloczkowski
October 1981, The American journal of physiology,
Maksim Kouza, and Anirban Banerji, and Andrzej Kolinski, and Irina Buhimschi, and Andrzej Kloczkowski
April 1976, Journal of electrocardiology,
Maksim Kouza, and Anirban Banerji, and Andrzej Kolinski, and Irina Buhimschi, and Andrzej Kloczkowski
May 2017, The journal of physical chemistry. A,
Maksim Kouza, and Anirban Banerji, and Andrzej Kolinski, and Irina Buhimschi, and Andrzej Kloczkowski
January 1997, Anticancer research,
Maksim Kouza, and Anirban Banerji, and Andrzej Kolinski, and Irina Buhimschi, and Andrzej Kloczkowski
October 2006, The journal of physical chemistry. B,
Maksim Kouza, and Anirban Banerji, and Andrzej Kolinski, and Irina Buhimschi, and Andrzej Kloczkowski
February 2017, Physical chemistry chemical physics : PCCP,
Maksim Kouza, and Anirban Banerji, and Andrzej Kolinski, and Irina Buhimschi, and Andrzej Kloczkowski
May 1986, Physical review letters,
Maksim Kouza, and Anirban Banerji, and Andrzej Kolinski, and Irina Buhimschi, and Andrzej Kloczkowski
May 1971, The Biochemical journal,
Maksim Kouza, and Anirban Banerji, and Andrzej Kolinski, and Irina Buhimschi, and Andrzej Kloczkowski
October 1961, Nature,
Maksim Kouza, and Anirban Banerji, and Andrzej Kolinski, and Irina Buhimschi, and Andrzej Kloczkowski
June 1994, Physical review. A, Atomic, molecular, and optical physics,
Copied contents to your clipboard!